This presentation is definitely worth a watch.
It's a bit tedius to find the talk as it is no longer live, recommend to filter by "Cancer Immunotherapy"
Shows the huge amount of work that has been involved to get the PD1-VAX and BVaxx developed.
Next B cell target that is almost ready is PD-L1 (Comparison is Tecentriq by Roche with $2b+ annual sales in 2019).
Upcoming combination trials with just our own drugs will give countless possibilities.
Interesting to see the bio's of the people who watched and which companies they represent a lot of the who's who of Big Pharma.
Ann: Investor Presentation, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |